InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: Steve43 post# 224573

Wednesday, 04/29/2020 12:58:25 PM

Wednesday, April 29, 2020 12:58:25 PM

Post# of 330581
For clarity, BIEL was leading the space with Dr. Scholl's, KT Tape and CVS, then BIEL reverted to its familiar toilet with a bizarre series of, "No!". Those deals were in the house, thanks to Keith Nalepka and he and shareholders were sabotaged by defective management. And that's just since Feb. 2017 when FDA OTC clearance was issued on the foot and knee.

Does the 'memory' of the former CEO deserve credit for numerous BIEL accomplishments? Of course, it would be dishonest not to recognize them. But as to legacy? The Dr. Scholl's, KT Tape and CVS deals were sabotaged by defective management.

The current 'CEO' inherited a mess, without question. The choice is hers. Fix a few things and make deals or stay in the BIEL toilet she was left with. Can she do that? Will she do that? Only time will tell.